ThOracoscopic Wedge Resection Treated With Chest Tube Removal Intraoperatively (TOTTI)

October 31, 2017 updated by: Bo Laksáfoss Holbek, Rigshospitalet, Denmark

Pain and Reasons for Hospitalization in Patients Treated Without Post-operative Chest Tube After Thoracoscopic Wedge Resection - A Randomized Controlled Study

Chest tubes are used routinely although preliminary studies demonstrate the feasibility and safety of intraoperative chest drain removal. Previous studies are however either retrospective or mainly concerning benign disease.

Hypothesis: Participants treated without post-operative chest tube after thoracoscopic wedge resection have less pain, better pulmonary function and similar complication profile than participants treated with standard post-operative chest tube, and could possibly be discharged earlier.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

90

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Elective thoracoscopic wedge resection
  • Speaks and understands Danish
  • FEV1 >= 60% of expected

Exclusion Criteria:

  • Increased risk of air leak evaluated by surgeon (large adhesions, bullae, emphysema, deep resection, etc.)
  • Increased risk of bleeding evaluated by surgeon (high INR, anticoagulation not paused, large bleeding, etc.)
  • Air leak on intraoperative sealing test
  • Patients previously included in study
  • Planned intraoperative frozen section with possible lobectomy
  • Previously included in current study
  • Planned frozen section diagnostics
  • Previous ipsilateral anatomic lung resection

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Chest tube group
Participants undergoing video-assisted thoracoscopic wedge resection with a positive intraoperative sealing test are treated with a standard post-operative chest tube.
A standard 28 Fr chest tube is inserted through the anterior port hole and all port holes are closed. With the tip of the chest tube below water, the pleura is emptied from air during continuous ventilation of the lungs. An air leak after 5 minutes of ventilation indicates a negative sealing test, whereas a cessation of air leak within 5 minutes indicates a positive sealing test.
A regular chest tube is left in the pleura.
Experimental: No chest tube group
Participants undergoing video-assisted thoracoscopic wedge resection with a positive intraoperative sealing test are treated with intraoperative chest tube removal.
A standard 28 Fr chest tube is inserted through the anterior port hole and all port holes are closed. With the tip of the chest tube below water, the pleura is emptied from air during continuous ventilation of the lungs. An air leak after 5 minutes of ventilation indicates a negative sealing test, whereas a cessation of air leak within 5 minutes indicates a positive sealing test.
Chest tube is removed intraoperatively.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Pain
Time Frame: Through post-operative admission, an average of 1 day.
Average pain expressed as area under the curve from a numeric rank score at 1, 3, 6 and 9 hours after surgery as well as daily at 8 am and 8 pm from post-operative day 1 until discharge.
Through post-operative admission, an average of 1 day.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Reasons for post-operative admission
Time Frame: Through post-operative admission, an average of 1 day.
Daily evaluation of reasons for admission.
Through post-operative admission, an average of 1 day.
Lung function
Time Frame: Up to post-operative day 1.
FEV1 measured preoperatively and on post-operative day 1 at 8 am.
Up to post-operative day 1.
Reinsertion of chest tubes
Time Frame: Up to post-operative day 30.
Frequency of chest tube reinsertion.
Up to post-operative day 30.
Pneumothorax
Time Frame: Up to post-operative day 1.
Size and frequency of pneumothorax on x-ray after removal of chest tube
Up to post-operative day 1.
Complications
Time Frame: Up to post-operative day 30.
Surgical complications including mortality.
Up to post-operative day 30.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Bo L. Holbek, MD, Rigshospitalet, Denmark
  • Study Director: Henrik J. Hansen, MD, Rigshospitalet, Denmark
  • Study Director: René H. Petersen, MD, Rigshospitalet, Denmark
  • Study Director: Henrik Kehlet, DMSc, Rigshospitalet, Denmark

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2016

Primary Completion (Anticipated)

July 1, 2018

Study Completion (Anticipated)

August 1, 2018

Study Registration Dates

First Submitted

July 8, 2016

First Submitted That Met QC Criteria

July 8, 2016

First Posted (Estimate)

July 12, 2016

Study Record Updates

Last Update Posted (Actual)

November 6, 2017

Last Update Submitted That Met QC Criteria

October 31, 2017

Last Verified

October 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain

Clinical Trials on Intraoperative sealing test

Subscribe